Nurix therapeutics will present trial in progress posters for two clinical programs at the 2022 annual european hematology association (eha) congress

Posters provide background information and trial designs for ongoing clinical studies of wholly-owned nx-2127 and nx-5948 programs posters provide background information and trial designs for ongoing clinical studies of wholly-owned nx-2127 and nx-5948 programs
NRIX Ratings Summary
NRIX Quant Ranking